Home Evotec And Ex Scientia Announce Partnership To Discover Bispecific Small Molecule Immuno-Oncology Therapeutics
 

Keywords :   


Evotec And Ex Scientia Announce Partnership To Discover Bispecific Small Molecule Immuno-Oncology Therapeutics

2016-05-03 03:19:19| drugdiscoveryonline News Articles

Evotec AG and ex scientia Ltd (Dundee, UK) recently announced a collaboration with the objective to discover and develop first-in-class bispecific small molecule immuno-oncology therapies

Tags: small partnership discover announce

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
More »